Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance

BMJ. 2019 Jul 29:366:l4486. doi: 10.1136/bmj.l4486.

Authors

Nicholas S Hopkinson¹, Andrew Molyneux², Joshua Pink³, Marie C Harrisingh³; Guideline Committee (GC)

Affiliations

¹ National Heart and Lung Institute, Imperial College, London, UK.
² Sherwood Forest Hospitals NHS Foundation Trust, Nottinghamshire, UK.
³ National Institute for Health and Care Excellence, London, UK.

PMID: 31358491
DOI: 10.1136/bmj.l4486

No abstract available

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Adrenergic beta-2 Receptor Agonists / therapeutic use
Anti-Bacterial Agents / therapeutic use
Asthma / complications
Asthma / drug therapy
Delayed-Action Preparations
Disease Progression
Humans
Metered Dose Inhalers
Muscarinic Antagonists / therapeutic use
Oxygen Inhalation Therapy
Patient Education as Topic
Pneumonectomy
Practice Guidelines as Topic*
Pulmonary Disease, Chronic Obstructive / complications
Pulmonary Disease, Chronic Obstructive / diagnosis*
Pulmonary Disease, Chronic Obstructive / therapy*
Self Care
United Kingdom

Substances

Adrenal Cortex Hormones
Adrenergic beta-2 Receptor Agonists
Anti-Bacterial Agents
Delayed-Action Preparations
Muscarinic Antagonists